Genetic basis of neurodegeneration in familial Alzheimer's disease

Polish Journal of Pharmacology

Volumn 56, Issue 2, 2004, Pages 171-178

  Kowalska, Anna ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

amyloid; Alzheimer's disease; Amyloid precursor protein; Mutation; Neurodegeneration; Presenilins; Secretases

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE INHIBITOR; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; NEW DRUG; PRESENILIN 1; PRESENILIN 2; PROTEIN INHIBITOR;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN INJURY; BRAIN NERVE CELL; BRAIN REGION; CELL LOSS; DEMENTIA; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HYPOTHESIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SENILE PLAQUE; SYNAPSE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; CELL DEATH; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NERVE DEGENERATION;

EID: 3142734397     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Blaker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT et al.: Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet, 2003, 12, 23-32.
2. Braak H, Braak E: Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging, 1994, 15, 355-356.
3. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS et al.: Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursors. J Biol Chem, 1998, 278, 27765-27767.
4. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C et al.: Early-onset autosomal dominant Alzheimer's disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet, 1999, 65, 664-670.
5. Citron M: β-Secretase as a target for the treatment of Alzheimer's disease. J Neurosci Res, 2002, 70, 373-379.
6. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C et al.: Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases protein production. Nature, 1992, 360, 672-674.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD et al.: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 1993, 261, 921-923.
8. Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R et al.: Estimation of the genetic contribution of presenilin-1 and presenilin-2 mutations in a population-based study of presenile Alzheimer's disease. Hum Mol Genet, 1998, 7, 43-51.
9. Daw EW, Payami H, Nemens EJ, Nochlin D, Schellenberg GD, Wijsman EM: The number of trait loci in late-onset Alzheimer's disease. Am J Hum Genet, 2000, 66, 196-204.
10. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K et al.: Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature, 1998, 391, 387-390.
11. Esler WP, Wolfe MS: A portrait of Alzheimer secretases - new features and familiar faces. Science, 2002, 293, 1449-1454.
12. Glenner G, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 1984, 120, 885-890.
13. Griffin WS, Sheng JG, Roberts GW, Mrak RE: Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol, 1995, 54, 276-281.
14. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA, 1986, 83, 4913-4917.
15. Hardy J, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256, 184-185.
16. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297, 353-356.
17. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B: Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol, 2000, 2, 461-462.
18. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS et al.: Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol Cell Neurosci, 1999, 14, 419-427.
19. Jarret JT, Lansbury PT: Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 1993, 73, 1055-1058.
20. Katzman R: Editorial: the prevalence and malignancy of Alzheimer's disease. A major killer. Arch Neurol, 1976, 33, 217-218.
21. Kowalska A: Molecular diagnostics of Alzheimer's disease. Diagn Lab, 2001, 37, Suppl, 129-134.
22. Kowalska A: Amyloid precursor protein gene mutations responsible for early-onset autosomal dominant Alzheimer's disease. Folia Neuropathol, 2003, 42, 35-40.
23. Kowalska A, Florczak J, Pruchnik-Wolinska D, Kraszewski A, Wender M: Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease. Arch Immunol Ther Exp, 1998, 46, 3, 177-181.
24. Kowalska A, Wender M: Mutations of presenilin genes and their role in the pathogenesis of Alzheimer's disease. Neur Neurochir Pol, 1998, 32, 1207-1217.
25. Kowalska A, Wiechmann I, Walter H: Genetic variability of apolipoprotein E in a Polish population. Hum Biol, 1998, 70, 6, 1093-1099.
26. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE et al.: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 1995, 269, 973-977.
27. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988, 240, 622-630.
28. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA: Caspase dependent DNA fragmentation might be associated with excitoxicity in Alzheimer's disease. J Neuropathol Exp Neurol, 1998, 57, 1041-1052.
29. Mattson M: Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol, 2000, 1, 120-129.
30. Olson MI, Shaw C-M: Presenile dementia and Alzheimer's disease in mongolism. Brain, 1969, 92, 147-156.
31. Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E et al.: Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology, 2001, 57, 621-625.
32. Sadot E, Gurwitz D, Barg J, Behar L, Ginzburg I, Fisher A: Activation of M1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem, 1996, 66, 877-880.
33. Selkoe DJ, Podlisny MB: Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genomics Hum Genet, 2002, 3, 67-99.
34. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H et al.: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 1995, 375, 754-760.
35. Strittmatter WJ, Sauders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA, 1993, 90, 1977-1981.
36. Tanzi RE, Gussella JF, Walkins PC, Bruns GA, St. George-Hyslop P, Van Keuren ML, Patterson D et al.: Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 1987, 235, 880-884.
37. Wegiel J, Wisniewski HM: The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol, 1990, 81, 116-124.
38. Wyss-Coray T, Mucke L: Inflammation in neurodegenerative disease - a double-edged sword. Neuron, 2002, 35, 419-432.
39. Xia W, Ray W, Rahmati T, Kimberly T, Wolfe M, Zhang J: Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation. Proc Natl Acad Sci USA, 2000, 97, 9299-9304.
40. Yu G, Nishimura M, Arakawa S, Levitan D, Zhang L, Tandon A: Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature, 2000, 407, 48-54.